Pharma Journalist -

ViiV Healthcare, the global specialist HIV company majority-owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, has announced it has made a regulatory submission to the…
Read More...

Atara Biotherapeutics, Inc. and Pierre Fabre announced an exclusive commercialization agreement for tabelecleucel (tab-cel) in Europe, Middle East, Africa, and other select emerging…
Read More...

Tonix Pharmaceuticals Holding Corp. (Tonix or the Company), a clinical-stage biopharmaceutical company, announced it has completed the acquisition of its new research and development…
Read More...

Kite, a Gilead Company announced the U.S. Food and Drug Administration (FDA) has granted approval for Tecartus (brexucabtagene autoleucel) for the treatment of adult patients (18 years…
Read More...

Takeda Pharmaceutical Company Limited and JCR Pharmaceuticals Co., Ltd. announced a geographically-focused exclusive collaboration and license agreement to commercialize JR-141 (INN:…
Read More...

Merck known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that molnupiravir (MK-4482, EIDD-2801), an investigational oral antiviral medicine,…
Read More...

SMi Group reports: SMi’s Medical Wearables for Biosensors conference chair interview with Andreas Caduff from Digital Medicine Society released The inaugural virtual Medical…
Read More...

Transcenta Holding Limited, a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based…
Read More...

Amgen announced that the U.S. Food and Drug Administration (FDA) has approved Repatha (evolocumab) as an adjunct to diet and other low-density lipoprotein cholesterol (LDL-C)-lowering…
Read More...

AstraZeneca has reached an agreement to collaborate with VaxEquity for the discovery, development and commercialisastion of the proprietary self-amplifying RNA (saRNA) therapeutics…
Read More...